Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Hudson Bay Capital Management LP IMPP Imperial Petroleum Inc./Marshall Islands 13G 9.99% 2y
JWM Family Enterprises, Inc. VAC MARRIOTT VACATIONS WORLDWIDE Corp 13G/A 5.6% 2y
CALDWELL SUTTER CAPITAL, INC. ELSE Electro Sensors Inc 13G/A 6.5% 2y
Hudson Bay Capital Management LP LUNR Intuitive Machines, Inc. 13G/A 0% 2y
Hacker Severin DUOL Duolingo, Inc. 13G/A 9.2% 2y
ALPS ADVISORS INC ENLC ENLINK MIDSTREAM, LLC 13G/A 9.08% 2y
COWEN AND COMPANY, LLC TRIS Tristar Acquisition I Corp. 13G 7.3% 2y
GOLDMAN SACHS GROUP INC OPEN Opendoor Technologies Inc. 13G/A 0.7% 2y
COWEN AND COMPANY, LLC ZPTA Zapata Quantum, Inc. 13G 7.2% 2y
COWEN AND COMPANY, LLC AIRJ AirJoule Technologies Corp. 13G 6.7% 2y
GOLDMAN SACHS GROUP INC SILK Silk Road Medical, Inc. Common Stock 13G 5.8% 2y
GOLDMAN SACHS GROUP INC RIGL Rigel Pharmaceuticals Inc 13G/A 0.1% 2y
GOLDMAN SACHS GROUP INC RYTM Rhythm Pharmaceuticals, Inc. 13G/A 8.5% 2y
COWEN AND COMPANY, LLC CVII Churchill Capital Corp VII Class A Common Stock 13G 6.26% 2y
GOLDMAN SACHS GROUP INC RSI Rush Street Interactive, Inc. 13G/A 4.2% 2y
GOLDMAN SACHS GROUP INC CASH Pathward Financial, Inc. 13G 5.6% 2y
GOLDMAN SACHS GROUP INC INTZ Intrusion Inc 13G/A 0% 2y
Mercury Capital, LLC PLMJF Plum Acquisition Corp. III 13D 20.02% 2y
AgCentral Energy Pty Ltd VSTE Vast Renewables Limited Ordinary Shares 13D 73.3% 2y
Scott E Rickert NMGX Nano Magic Inc. 13D/A 7.4% 2y
Fisher Asset Management, LLC WGO Winnebago Industries Inc 13G 1.8% 2y
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP UNCY Unicycive Therapeutics, Inc. 13G 6.1% 2y
Fisher Asset Management, LLC RVLV Revolve Group, Inc. 13G 0% 2y
Fisher Asset Management, LLC GTHX G1 Therapeutics, Inc. Common Stock 13G 0% 2y
IMA Value LLP RAVE Rave Restaurant Group, Inc. 13D/A 7.04% 2y
Fund 1 Investments, LLC TLYS Tilly's, Inc. 13D/A 31.31% 2y
GAMCO INVESTORS, INC. ET AL RDI Reading International Inc 13D/A 4.43% 2y
Spring River Greater China Fund CAN Canaan Inc. 13G/A 4.6% 2y
Gerald E. O’Shaughnessy GPRK GeoPark Ltd 13D/A 6.29% 2y
Koller Therese A. SNDR Schneider National, Inc. 13D/A 19.6% 2y
GLOBAL VALUE INVESTMENT CORP. RMCF Rocky Mountain Chocolate Factory, Inc. 13D/A 16.75% 2y
MILTON C. AULT, III ALZN Alzamend Neuro, Inc. 13D/A 40.3% 2y
AGMAN INVESTMENTS LLC PBPB Potbelly Corporation Common Stock 13G/A 0.31% 2y
Zimmermann Kathleen M. SNDR Schneider National, Inc. 13D/A 17.8% 2y
Schneider Paul J. SNDR Schneider National, Inc. 13D/A 16.7% 2y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 20.58% 2y
BROWNING WEST LP GIL Gildan Activewear Inc. 13D/A 5% 2y
DePrey Mary P. SNDR Schneider National, Inc. 13D/A 17.2% 2y
5AM Ventures VI, L.P. ELVN Enliven Therapeutics, Inc. 13D/A 11.3% 2y
PAVmed Inc. LUCD Lucid Diagnostics Inc. 13D/A 72.2% 2y
Mitchell P. Kopin RDHL RedHill Biopharma Ltd. 13G 4% 2y
BCLS Fund III Investments, LP DNTH Dianthus Therapeutics, Inc. 13G 9.99% 2y
RA CAPITAL MANAGEMENT, L.P. DNTH Dianthus Therapeutics, Inc. 13G 9.99% 2y
RiverVest Venture Fund III, L.P. ALLK Allakos Inc. 13D/A 0.2% 2y
Soleus Capital Master Fund, L.P. FOCL Edap Tms SA 13G/A 19.6% 2y
General Electric Co GEHC GE HealthCare Technologies Inc. 13G/A 13.5% 2y
Dapice Joshua J. PTGX Protagonist Therapeutics, Inc 13G/A 9.99% 2y
Soleus Capital Master Fund, L.P. AXGN Axogen, Inc. 13G/A 6% 2y
BlackRock Inc. CRGY Crescent Energy Co 13G 6.8% 2y
Hudson Bay Capital Management LP DISA Disruptive Acquisition Corporation I Class A Ordinary Shares 13G/A 0% 2y